CITIUS PHARMACEUTICALS INC (CTXR) Stock Analyst Earnings Estimates
NASDAQ:CTXR - Nasdaq - US17322U3068 - Common Stock - Currency: USD
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 365.90% | N/A 118.26% | N/A 50.12% | N/A 21.43% | N/A 14.48% | N/A 13.34% | N/A -31.76% | ||||||||||||
| EBITDA YoY % growth | N/A | N/A | -7.45M | -9.99M -34.09% | -13.79M -38.04% | -15.6M -13.13% | -17.71M -13.53% | -23.54M -32.92% | -33.32M -41.55% | -36.538M -9.66% | -41.786M -14.36% | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EBIT YoY % growth | -650K | -3.23M -396.92% | -7.45M -130.65% | -9.99M -34.09% | -13.79M -38.04% | -15.6M -13.13% | -17.71M -13.53% | -23.54M -32.92% | -33.32M -41.55% | -36.732M -10.24% | -41.996M -14.33% | N/A 29.84% | N/A 175.67% | N/A 322.73% | N/A 59.30% | N/A 26.67% | N/A 17.28% | N/A 15.63% | N/A -28.50% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A | N/A | -0.78 98.05% | -0.46 41.03% | -0.27 41.30% | -0.22 18.52% | N/A -1,754.55% | -4.40 -7.89% | N/A 24.46% | N/A 141.87% | N/A 121.98% | N/A -9.57% | N/A 13.87% | N/A 4.49% | N/A 8.90% | N/A 3.66% |
All data in USD
| Q3 / 25 | Q4 / 25 | Q1 / 26 | Q2 / 26 | Q3 / 26 | Q4 / 26 | |
|---|---|---|---|---|---|---|
| EPS Q2Q % growth | -0.60 59.88% | -0.30 80.99% | -0.01 99.22% | -0.20 83.94% | 4.85 905.08% | 5.36 1,869.64% |
| Revenue Q2Q % growth | 4.405M | 11.585M | 15.902M | 16.593M | 44.085M 900.79% | 48.643M 319.88% |
| EBITDA Q2Q % growth | N/A | N/A | N/A | N/A | N/A | N/A |
| EBIT Q2Q % growth | -7.006M 34.12% | -1.936M 82.48% | -476.34K 95.26% | -497.76K 95.58% | N/A | N/A |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | -1.27 -1.60% | -0.39 | -0.88 | -224.81% |
| Q1 2025 Q2Q % growth | -1.30 -2,066.67% | -0.59 | -0.71 | -121.01% |
| Q4 2024 Q2Q % growth | -1.59 -1,890.00% | -1.53 | -0.06 | -4.05% |
| Q3 2024 Q2Q % growth | -1.50 -2,400.00% | -1.28 | -0.23 | -17.65% |
| Q2 2024 Q2Q % growth | -1.25 -1,685.71% | -1.53 | 0.28 | 18.30% |
| Q1 2024 Q2Q % growth | -0.06 | 0.13 | -0.19 | -145.25% |
| Q4 2023 Q2Q % growth | -0.08 -60.00% | -0.02 | -0.06 | -292.16% |
| Q3 2023 Q2Q % growth | -0.06 | -0.06 | 0.00 | -6.95% |
| Q2 2023 Q2Q % growth | -0.07 -40.00% | -0.04 | -0.03 | -96.08% |
| Q4 2022 Q2Q % growth | -0.05 -150.00% | -0.04 | -0.01 | -22.55% |
| Q3 2022 Q2Q % growth | -0.06 | -0.05 | -0.01 | -17.65% |
| Q2 2022 Q2Q % growth | -0.05 -25.00% | -0.07 | 0.02 | 29.97% |
| Q1 2022 Q2Q % growth | -0.06 60.00% | -0.06 | 0.00 | 1.96% |
| Q4 2021 Q2Q % growth | -0.02 71.43% | -0.04 | 0.02 | 50.98% |
| Q3 2021 Q2Q % growth | -0.06 45.45% | -0.07 | 0.01 | 9.50% |
| Q2 2021 Q2Q % growth | -0.04 69.23% | -0.08 | 0.04 | 47.71% |
| Q1 2021 Q2Q % growth | -0.15 | 0.16 | -0.31 | -191.91% |
| Q4 2020 Q2Q % growth | -0.07 56.25% | -0.11 | 0.04 | 34.64% |
| Q3 2020 Q2Q % growth | -0.11 45.00% | -0.11 | 0.00 | -2.71% |
| Q2 2020 Q2Q % growth | -0.13 35.00% | -0.10 | -0.03 | -27.45% |
| Q1 2020 Q2Q % growth | -0.15 31.82% | -0.14 | -0.01 | -5.04% |
| Q4 2019 Q2Q % growth | -0.16 | -0.14 | -0.02 | -12.04% |
| Q2 2019 Q2Q % growth | -0.20 | -0.20 | 0.00 | 1.96% |
| Q1 2019 Q2Q % growth | -0.22 | -0.21 | -0.01 | -2.71% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2025 Q2Q % growth | 2.721M | -2.721M | -100.00% | |
| Q1 2025 Q2Q % growth | 7.202M | -7.202M | -100.00% | |
| Q1 2024 Q2Q % growth | 21.721M | -21.721M | -100.00% | |
| Q1 2021 Q2Q % growth | 19.154M | -19.154M | -100.00% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | -0.85% | 16.51% | -386.57% | -79.12% |
| Revenue | 0% | 9.44% | 0% | 11.92% |